For: | Rahman FZ, Takhar GK, Roy O, Shepherd A, Bloom SL, McCartney SA. Henoch-Schönlein purpura complicating adalimumab therapy for Crohn’s disease. World J Gastrointest Pharmacol Ther 2010; 1(5): 119-122 [PMID: 21577306 DOI: 10.4292/wjgpt.v1.i5.119] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v1/i5/119.htm |
Number | Citing Articles |
1 |
Carmen Muñoz Villafranca, Rosa Maria Izu Belloso, Maria Teresa Bravo Rodriguez, Susana Basterra Olabarrieta. Vasculitis por adalimumab en un paciente con enfermedad de Crohn. Gastroenterología y Hepatología 2013; 36(4): 296 doi: 10.1016/j.gastrohep.2012.10.004
|
2 |
Xiaolu Li, Yizhong Wang, Ting Ge, Yongmei Xiao, Ting Zhang. Henoch-Schönlein purpura associated with infliximab therapy for pediatric Crohn’s disease. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e1074 doi: 10.1097/MEG.0000000000002046
|
3 |
Tumay Ak, Rana Berru Durmus, Muhammed Onel. Cutaneous vasculitis associated with molecular tergeted therapies: systematic review of the literature. Clinical Rheumatology 2023; 42(2): 339 doi: 10.1007/s10067-022-06406-6
|
4 |
Joseph J. LaConti, Jean A. Donet, Jeong Hee Cho-Vega, Daniel A. Sussman, Dana Ascherman, Amar R. Deshpande. Henoch-Schönlein Purpura with Adalimumab Therapy for Ulcerative Colitis: A Case Report and Review of the Literature. Case Reports in Rheumatology 2016; 2016: 1 doi: 10.1155/2016/2812980
|
5 |
M Villatoro-Villar, CS Crowson, KJ Warrington, A Makol, MJ Koster. Immunoglobulin A vasculitis associated with inflammatory bowel disease: a retrospective cohort study. Scandinavian Journal of Rheumatology 2021; 50(1): 40 doi: 10.1080/03009742.2020.1732460
|
6 |
Kenichi Kishimoto, Kousaku Kawashima, Mai Fukunaga, Satoshi Kotani, Hiroki Sonoyama, Akihiko Oka, Yoshiyuki Mishima, Naoki Oshima, Norihisa Ishimura, Noriyoshi Ishikawa, Riruke Maruyama, Shunji Ishihara. Intermittent Purpura Development Associated with Leukocytoclastic Vasculitis Induced by Infliximab for Crohn's Disease. Internal Medicine 2021; 60(3): 385 doi: 10.2169/internalmedicine.5340-20
|
7 |
Hemal N. Sampat, Brian P. McAllister, Darryl D. Gaines, Barbara Ostrov. Terminal Ileitis as a Feature of Henoch-Schönlein Purpura Masquerading as Crohn Disease in Adults. JCR: Journal of Clinical Rheumatology 2016; 22(2): 82 doi: 10.1097/RHU.0000000000000361
|
8 |
Roberto Perez-Alvarez, Marta Pérez-de-Lis, Manuel Ramos-Casals. Biologics-induced autoimmune diseases. Current Opinion in Rheumatology 2013; 25(1): 56 doi: 10.1097/BOR.0b013e32835b1366
|
9 |
Lindsey G. Albenberg, Petar Mamula, Kurt Brown, Robert N. Baldassano, Pierre Russo. Pathology of Pediatric Gastrointestinal and Liver Disease. 2014; : 197 doi: 10.1007/978-3-642-54053-0_6
|
10 |
Sarah Alsulami, Rakan M Alotaibi, Faisal F Alotaibi, Faisal B Almatrafi, Doaa M Filmban, Sultan Alneefia, AhmedHusam Alahmed, Waleed A Hafiz. IgA Vasculitis With Adalimumab Therapy for Hidradenitis Suppurativa: A Case Report and Review of Literature. Cureus 2022; doi: 10.7759/cureus.30122
|
11 |
Camila da Silva Cendon Duran, Adriane Souza da Paz, Mittermayer Barreto Santiago. Vasculitis induced by biological agents used in rheumatology practice: A systematic review. Archives of Rheumatology 2022; 37(2): 300 doi: 10.46497/ArchRheumatol.2022.9049
|
12 |
Yang Song, Yan-Hong Shi, Chong He, Chang-Qin Liu, Jun-Shan Wang, Yu-Jie Zhao, Yan-Min Guo, Rui-Jin Wu, Xiao-Yue Feng, Zhan-Ju Liu. Severe Henoch-Schönlein purpura with infliximab for ulcerative colitis. World Journal of Gastroenterology 2015; 21(19): 6082-6087 doi: 10.3748/wjg.v21.i19.6082
|
13 |
Carmen Martín Varas, Manuel Heras, Ana Saiz, Raquel Coloma, Leonardo Calle, Ramiro Callejas, Álvaro Molina, María Astrid Rodríguez, María José Fernández-Reyes Luis. Vasculitis asociada a anticuerpo anticitoplasma de neutrófilo en paciente con enfermedad de Crohn en tratamiento con adalimumab. Nefrología 2017; 37(5): 560 doi: 10.1016/j.nefro.2017.03.009
|
14 |
Woo-Jin Jung, Yoon-Jeong Nam, Seung-Geun Lee, Ji-Min Kim, Margaret Song, Moon-Bum Kim, Geun-Tae Kim. Henoch-Schönlein Purpura in a Patient with Ankylosing Spondylitis after Infliximab Therapy. Korean Journal of Medicine 2013; 84(5): 764 doi: 10.3904/kjm.2013.84.5.764
|
15 |
Morgane Condamina, Emmanuelle Diaz, Céline Jamart, Jeffrey Loget, Anne Durlach, Jean-Hugues Salmon, Guillaume Cadiot, Manuelle Viguier. Severe Attack of Henoch-Schönlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn’s Disease. Journal of Crohn's and Colitis 2020; 14(4): 538 doi: 10.1093/ecco-jcc/jjz164
|
16 |
Iman Hemmati, Jason Kur. Adalimumab-associated antiphospholipid syndrome: a case report and review of the literature. Clinical Rheumatology 2013; 32(7): 1095 doi: 10.1007/s10067-013-2244-0
|
17 |
Yun Xue, Jeffrey M. Cohen, Natalie A. Wright, Joseph F. Merola. Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects. American Journal of Clinical Dermatology 2016; 17(2): 147 doi: 10.1007/s40257-015-0167-z
|
18 |
Dean Edwards, Eli Boritz, Edward W. Cowen, Ronald S. Brown. Erythema multiforme major following treatment with infliximab. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2013; 115(2): e36 doi: 10.1016/j.oooo.2012.08.001
|
19 |
Anishka S. Rolle, Bernard Zimmermann, Sam H. Poon. Etanercept-Induced Henoch-Schönlein Purpura in a Patient With Ankylosing Spondylitis. Journal of Clinical Rheumatology 2013; 19(2): 90 doi: 10.1097/RHU.0b013e3182863027
|
20 |
Shintaro Yamamoto, Tomoyuki Mukai, Shunichi Fujita, Yoshitaka Morita. Certolizumab pegol-induced immunoglobulin A vasculitis in a patient with rheumatoid arthritis. Medicine: Case Reports and Study Protocols 2021; 2(1): e0029 doi: 10.1097/MD9.0000000000000029
|
21 |
Camille Rasmussen, Vered Abitbol, Khalil El Karoui, Anne Bourrier, Romain Paule, Lucine Vuitton, François Maurier, David Laharie, Mathurin Fuméry, Christian Agard, Michael Collins, Stephane Nancey, Cédric Rafat, Anne-Gaëlle Kervegant, Viviane Queyrel-Moranne, Guillaume Moulis, Bénédicte Pigneur, Alexis Régent, Claire Gay, Caroline Morbieu, Cécile Audrey Durel, Didier Ducloux, François Aubin, Mickaela Voicu, Nizar Joher, Tali Szwebel, Christine Martinez-Vinson, Stéphane Koch, Loïc Guillevin, Laurent Peyrin-Biroulet, Benjamin Terrier. IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockers. Rheumatology 2022; 61(5): 1957 doi: 10.1093/rheumatology/keab662
|
22 |
Inês Marques, Ana Lagos, Jorge Reis, António Pinto, Beatriz Neves. Reversible Henoch–Schönlein purpura complicating adalimumab therapy. Journal of Crohn's and Colitis 2012; 6(7): 796 doi: 10.1016/j.crohns.2012.02.019
|
23 |
V. Roumieu, A. Darmon, P. Belenotti, A. Benyamine, J. Serratrice, P. Lafforgue, P.J. Weiller. Purpura rhumatoïde sous anti-TNF : à propos de deux cas. La Revue de Médecine Interne 2014; 35: A117 doi: 10.1016/j.revmed.2014.10.195
|
24 |
M. Reverte, M. Etienne, M. Fouchard, L. Doucet, E. Brenaut, L. Misery. Occurrence of Henoch–Schönlein purpura in a patient treated with secukinumab. Journal of the European Academy of Dermatology and Venereology 2019; 33(12) doi: 10.1111/jdv.15776
|
25 |
Carmen Martín Varas, Manuel Heras, Ana Saiz, Raquel Coloma, Leonardo Calle, Ramiro Callejas, Álvaro Molina, María Astrid Rodríguez, María José Fernández-Reyes Luis. Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab. Nefrología (English Edition) 2017; 37(5): 560 doi: 10.1016/j.nefroe.2017.09.006
|